Viewray Inc Quick Ratio (VRAY) starting from the first quarter 2023 to first quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Viewray Inc   (NASDAQ: VRAY)

Viewray Inc 's Quick Ratio

VRAY's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the first quarter 2023, Quick Ratio fell to 0.49 below Viewray Inc average.

Within Medical Equipment & Supplies industry 174 other companies have achieved higher Quick Ratio than Viewray Inc in first quarter 2023. While Quick Ratio total ranking in the first quarter 2023 has deteriorated compared to the prior quarter from 710 to 3001.

Explain Quick Ratio?
How much Cash & cash equivalents VRAY´s has?
What are VRAY´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VRAY Quick Ratio (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Dec 31 2021)
Q2		 (Sep 30 2021)
Q1
Y / Y Current Liabilities Change 494.64 % 82.26 % -18.21 % 27.94 % -65.5 %
Y / Y Cash & cash equivalent Change -45.77 % -18.55 % -21.83 % 39.32 % -8.53 %
Quick Ratio MRQ 0.49 1.41 3.54 2.86 5.34
VRAY's Total Ranking # 3001 # 710 # # #
Seq. Current Liabilities Change 72.67 % 140.03 % -47.22 % 171.85 % -47.08 %
Seq. Cash & cash equivalent Change -40.21 % -4.44 % -34.84 % 45.66 % -10.2 %



Quick Ratio first quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 175
Healthcare Sector # 968
Overall Market # 3001


Quick Ratio Statistics
High Average Low
4.54 1.69 0.12
(Sep 30 2018)   (May 31 2014)




Financial Statements
Viewray Inc 's Current Liabilities $ 167 Millions Visit VRAY's Balance sheet
Viewray Inc 's Cash & cash equivalent $ 81 Millions Visit VRAY's Balance sheet
Source of VRAY's Sales Visit VRAY's Sales by Geography


Cumulative Viewray Inc 's Quick Ratio

VRAY's Quick Ratio for the trailling 12 Months

VRAY Quick Ratio

 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Dec 31 2021)
12 Months		 (Sep 30 2021)
12 Months
Y / Y Current Liabilities TTM Growth 100.09 % -0.81 % -23.55 % -22.8 % -29.45 %
Y / Y Cash & cash equivalent TTM Growth -11.85 % -3.44 % -0.69 % 3.89 % -13.79 %
Quick Ratio TTM 1.52 2.68 3.43 3.47 3.45
Total Ranking TTM # 4467 # 390 # # #
Seq. Current Liabilities TTM Growth 57.54 % 22.07 % -4.34 % 8.77 % -21.91 %
Seq. Cash & cash equivalent TTM Growth -10.61 % -4.57 % -5.54 % 9.4 % -2.09 %

Quick ratio ranking by company, industry and sector >> Back to VRAY Financial Strength Comparisons >> Go to Compare VRAY Quick Ratio to its Competitors

On the trailing twelve months basis Due to jump in Current Liabilities in the Q1 2023 to $166.77 millions, cumulative Quick Ratio decreased to 1.52 below the Viewray Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 245 other companies have achieved higher Quick Ratio than Viewray Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2022 from 390 to 4467.

Explain Quick Ratio?
How much Cash & cash equivalents VRAY´s has?
What are VRAY´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 246
Healthcare Sector # 1166
Within the Market # 4467


trailing twelve months Quick Ratio Statistics
High Average Low
3.08 2.21 0.34
(Jun 30 2022)   (Dec 31 2016)




Companies with similar Quick Ratio in the quarter ending Mar 31 2023, within Medical Equipment & Supplies Industry Quick RatioMar 31 2023 MRQ Cash & cash equivalentMar 31 2023 MRQ Current Liabilities
Endra Life Sciences Inc  1.29 $ 2.355  Millions$ 1.832  Millions
Lakeland Industries Inc   1.27 $ 26.021  Millions$ 20.533  Millions
Electromedical Technologies Inc   1.25 $ 1.235  Millions$ 0.988  Millions
Cerus Corporation  1.22 $ 94.680  Millions$ 77.573  Millions
Innovage Holding Corp   1.22 $ 167.553  Millions$ 137.689  Millions
Accuray Incorporated  1.18 $ 89.057  Millions$ 75.594  Millions
Biolife Solutions Inc   1.16 $ 54.885  Millions$ 47.319  Millions
Edwards Lifesciences Corporation  1.16 $ 1,254.200  Millions$ 1,082.000  Millions
Universal Biosensors Inc   1.14 $ 14.048  Millions$ 12.371  Millions
Haemonetics Corporation  1.13 $ 284.466  Millions$ 251.816  Millions
Surgalign Holdings Inc   1.12 $ 22.430  Millions$ 19.984  Millions
Docgo Inc   1.10 $ 120.057  Millions$ 108.975  Millions
Cadre Holdings inc   1.10 $ 48.294  Millions$ 43.868  Millions
Jin Medical International Ltd  1.09 $ 9.769  Millions$ 8.924  Millions
Integra Lifesciences Holdings Corp  1.09 $ 307.367  Millions$ 282.293  Millions
Brainsway Ltd   1.08 $ 10.520  Millions$ 9.761  Millions
Electromed Inc   1.06 $ 6.776  Millions$ 6.417  Millions
Establishment Labs Holdings Inc   1.03 $ 42.847  Millions$ 41.471  Millions
Sonoma Pharmaceuticals Inc   1.03 $ 3.820  Millions$ 3.717  Millions
Privia Health Group Inc   1.01 $ 311.229  Millions$ 306.668  Millions
Agape Atp Corporation  1.00 $ 1.120  Millions$ 1.116  Millions
Surmodics Inc   1.00 $ 19.180  Millions$ 19.130  Millions
Pavmed Inc   1.00 $ 49.280  Millions$ 49.282  Millions
Plus Therapeutics Inc   0.99 $ 12.723  Millions$ 12.796  Millions
Embecta Corp   0.97 $ 346.400  Millions$ 357.700  Millions
Inspiremd Inc   0.96 $ 4.228  Millions$ 4.383  Millions
Glucotrack Inc   0.96 $ 1.003  Millions$ 1.047  Millions
Heartsciences Inc   0.92 $ 1.660  Millions$ 1.803  Millions
Adm Tronics Unlimited Inc   0.90 $ 1.004  Millions$ 1.114  Millions
Vivos Therapeutics Inc   0.88 $ 7.046  Millions$ 7.975  Millions

Date modified: 2026-09-26T06:50:50+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.